Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin and silicone oil at the end of vitrectomy for diabetic tractional retinal detachment
IRCT201106284856N3Phase 2Completed
- Sponsor
- Baqiyatallah University of Medical Sciences
- Start
- Jul 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bevacizumab in Tractional retinal detachment (TRD) and proliferative diabetic retinopathy (PDR), sponsored by Baqiyatallah University of Medical Sciences. Started Jul 2011; status: completed.
02
Drugs
bevacizumab
03
Conditions
Tractional retinal detachment (TRD)proliferative diabetic retinopathy (PDR)
Beyond the preview
Go deeper on IRCT201106284856N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201106284856N3.